Jump to content

clubkidjeff

Members
  • Content Count

    369
  • Joined

  • Last visited

2 Followers

About clubkidjeff

  • Rank
    Recurring

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. I was taking baby steps to get used to Chanel and Precious Way. Hmm, I wonder what happened...
  2. JMW had some good material, which earned her a Lead Actress nomination...
  3. THIS. I was about to share the link. Nice interview, yes a twin would be good...JL seems like a swell guy. Right?! Right!
  4. Thank you for sharing, hopefully you are able to rectify things...
  5. Shows seem to fare better when the whole week doesn't air except the tank in GH demos.
  6. Thank you. BTW, it's amazing what hair, make-up and wardrobe do, I wouldn't have recognized MM in this picture. https://www.soapoperadigest.com/photos/social-snaps-1698235/
  7. Right...looks like this story is a flop.
  8. Thomas and the Hope doll didn't start until this past week, end of Wednesday's episode. So we'll see how next week's numbers are...but I have my doubts...unless viewers tune in just to "see what it is all about". ...Right about Days?!
  9. The Hope mannequin is definitely unlike Brad Bell...We'll see if this storyline lures viewers or chases them away.
  10. https://www.viacomcbspressexpress.com/cbs-entertainment/releases/view?id=56122 For the week ending Friday, Oct. 9, THE YOUNG AND THE RESTLESS reached 3.08 million viewers, while THE BOLD AND THE BEAUTIFUL attracted 2.93 million viewers – both daytime dramas’ largest audiences in over five months, since the week ending April 24. ...B&B inching closer to Y&R.
  11. I'll refrain from the tabloid title and political discussion, and just say "Ooh...Mark Valley".
  12. This cracks me up! Agree with GLATWT88 too, wasn't sure what numbers to expect for BB (but probably better than this). Adding, I've been enjoying Days' last four wedding-themed weeks, been noticing an increase each week.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use and Privacy Policy